SAS Output

22-SEP-2017 18:10

BREAST ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 Y 1 Recurrence Score testing 9400 9365 777 378 172 66 15 02/28/2011 413 205
            9365 777 378 172 66 15      
 
    2 Y 2 Chemo and Endocrine Therapy 4000 2529 257 128 57 17 5 02/28/2011    
        3 Endocrine Therapy Alone   2518 258 124 55 20 5      
            5047 515 252 112 37 10      
 
  S1207-Brst,Adj,Endocrine+/-Everolimus 1 Y 1 Blinded drug + Endocrine 1900 677 213 106 45 18 5 09/12/2013 458 239
        2 Blinded drug + Endocrine   679 217 106 53 23 2      
            1356 430 212 98 41 7      
 
  S1222-Brst,Fulv. +/- Ever. +/- Anastr. 1 T 1 Blinded treatment 840 12 0 0 0 0 0 05/15/2014 16 6
        2 Blinded treatment   12 0 0 0 0 0      
        3 Blinded treatment   13 0 0 0 0 0      
            37 0 0 0 0 0      
 
  S1416-Brst, TNBC/BRCA, Cis+/- ABT-888 1 Y 1 Blinded Drug + Cisplatin 333 69 69 41 19 8 1 09/15/2016 264 124
        2 Blinded Drug + Cisplatin   66 64 43 16 5 1      
            135 133 84 35 13 2      
 
  S1418-Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 Y 1 Tissue for PD-L1 testing 1000 81 81 70 43 20 4 01/18/2017 382 165
            81 81 70 43 20 4      
 
    2 Y 2 Observation 1000 32 32 30 16 8 0 01/18/2017    
        3 MK-3475 (Pembrolizumab)   34 34 31 18 7 2      
            66 66 61 34 15 2      
 
Yes A011106-Breast, Neoadj, ALTERNATE study 1 E Total Registrations   49 26 16 11 5 2 04/29/2014 249 115
            49 26 16 11 5 2      
 
  E1Z11-Brst,Genetic Predictors of AIMSS 1 E Total Registrations   144 8 6 2 0 0 08/13/2013 259 86
            144 8 6 2 0 0      
 
No A011202-Breast, Nodal XRT +/- ALND 0 E Total Registrations   137 54 30 14 7 1 03/20/2014 338 179
            137 54 30 14 7 1      
 
    1 E Total Registrations   54 19 9 4 2 0 03/20/2014    
            54 19 9 4 2 0      
 
  A011401-Breast, adj, Stage II/III HER2-, weight loss 1 E Total Registrations   74 74 51 26 6 2 10/05/2016 403 220
            74 74 51 26 6 2      
 
    2 E Total Registrations   62 62 43 29 5 0 10/05/2016    
            62 62 43 29 5 0      
 
  A011502-Brst, Adj, Nodal+&HER2-, Aspirin vs. Placebo 1 E Total Registrations   14 14 13 9 2 0 03/20/2017   190
            14 14 13 9 2 0      
 
  A221405-Breast, ET interruption, Pregnancy Outcomes 1 E Total Registrations   2 2 2 0 0 0 05/08/2017   14
            2 2 2 0 0 0      
 
  B51-Breast, Regional Nodal XRT 1 E Total Registrations   18 10 6 4 1 0 06/13/2014 417 216
            18 10 6 4 1 0      
 
  B55-Brst, Adj Olaparib for BRCA,TNBC 1 E Total Registrations   43 20 6 2 2 1 12/15/2014 409 181
            43 20 6 2 2 1      
 
    2 E Total Registrations   18 8 3 0 0 0 12/15/2014    
            18 8 3 0 0 0      
 
  E2112-Brst,Adv,Exemestane+/-Entinostat 1 E Total Registrations   39 17 10 4 1 0 04/01/2015 289 167
            39 17 10 4 1 0      
 
  EA1131-Brst, TNBC, Post-op Chemo vs Obs 0 E Total Registrations   14 9 8 4 1 1 11/12/2015 300 123
            14 9 8 4 1 1      
 
    1 P Total Registrations   6 5 5 4 1 0 11/12/2015    
            6 5 5 4 1 0      
 
  NRGBR003-Brst,Adj,TNBC,AC -> WP +/- Carbo 1 E Total Registrations   42 21 15 5 3 2 10/16/2015 422 216
            42 21 15 5 3 2